Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Leukemia, Myeloid, Acute 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Myelodysplastic Syndromes 15Hematologic Neoplasms 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7Lymphoma, Non-Hodgkin 6Neuroblastoma 5Leukemia, Biphenotypic, Acute 5Myeloproliferative Disorders 4Graft vs Host Disease 4Multiple Myeloma 3Medulloblastoma 3Lymphoma, Large B-Cell, Diffuse 3Leukemia 3Hodgkin Disease 3Ganglioneuroblastoma 3Blastic Plasmacytoid Dendritic Cell Neoplasm 3Lymphoma 2Leukemia, Myelomonocytic, Juvenile 2Leukemia, Myelomonocytic, Chronic 2Anemia, Refractory, with Excess of Blasts 2Teratoma 1Sarcoma, Myeloid 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Recurrence 1Pyloric Stenosis, Hypertrophic 1Pinealoma 1Neurofibrosarcoma 1

Interventions

Magnetic Resonance Spectroscopy 8X-Rays 7Phantoms, Imaging 7Cyclophosphamide 7Specimen Handling 6Nuclear Medicine Department, Hospital 5fludarabine 4Etoposide 4Biopsy 4tazemetostat 3etoposide phosphate 3Vincristine 3Temozolomide 3Nivolumab 3Cisplatin 3Carboplatin 3Automobiles 3ulixertinib 2tipifarnib 2selpercatinib 2palbociclib 2larotrectinib 2ivosidenib 2erdafitinib 2ensartinib 2Topotecan 2Sirolimus 2Methotrexate 2Mesna 2LY3023414 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rhabdoid Tumor × Thiotepa × 1 year × Clear all
NCT06942039 2026-02-27

Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation

C17 Council

Phase EARLY_PHASE1 Recruiting
15 enrolled
CNS

Medulloblastoma, Neuroblastoma, Pinealoma, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor, Pyloric Stenosis, Hypertrophic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡